77 related articles for article (PubMed ID: 310195)
1. [Typing of HLA-DR antigens on B lymphocytes--a problem of B-lymphocyte-suspension quality and specificity of anti-HLA-DR serums].
Májský A
Vnitr Lek; 1978 Dec; 24(12):1209-16. PubMed ID: 310195
[No Abstract] [Full Text] [Related]
2. [The problem of preparing avid cytotoxic anti-B-lymphocyte serums].
Májský A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):142-6. PubMed ID: 77815
[TBL] [Abstract][Full Text] [Related]
3. Characterization of different patterns of antibody reactivity in highly sensitized dialysis patients.
Barocci S; Valente U; Carozzi S; Leprini A; Mantero D; Fontana I; Cantarella S; Millo R; Gusmano R; Nocera A
Transplant Proc; 1988 Oct; 20(5):951-3. PubMed ID: 3263721
[No Abstract] [Full Text] [Related]
4. [HLA-DR antigen typing using the 2-color fluorescence test; the specificity and sensitivity of the method in comparison with the monocytotoxicity and B-lymphocytotoxicity tests].
Májský A
Vnitr Lek; 1991 Mar; 37(3):279-84. PubMed ID: 2031317
[TBL] [Abstract][Full Text] [Related]
5. [Locus HLA-DR--specific antigens of B lymphocytes. Comprehensive review].
Májský A
Vnitr Lek; 1978 Nov; 24(11):1092-1101. PubMed ID: 82296
[No Abstract] [Full Text] [Related]
6. Dilutions and specificity analysis of pretransplant sera.
Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
[TBL] [Abstract][Full Text] [Related]
7. [Studies on HLA-DR typing method --micro lymphocyte cytotoxicity test (author's transl)].
Shiwaku Y; Morita N; Shingami T; Mori H; Nakao Y; Hashimoto S
Igaku Kenkyu; 1979 Sep; 49(3):227-35. PubMed ID: 547637
[No Abstract] [Full Text] [Related]
8. [T and B lymphocyte subpopulations with HLA-DR surface molecules in rheumatoid arthritis, using a monoclonal lymphocytotoxic antibody. Poorly and highly developed rheumatoid arthritis].
Mercier P; Dallest R; Olmeta C; Gaborit P; Gatti P; Roux H
Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):713-9. PubMed ID: 6975966
[TBL] [Abstract][Full Text] [Related]
9. [Different cytotoxic reactivity of anti-HLA A or B sera against sub-population of human lymphocytes prepared with different methods].
Richiardi P; Crepaldi T; Curtoni ES
G Batteriol Virol Immunol; 1980; 73(7-12):180-9. PubMed ID: 6975729
[No Abstract] [Full Text] [Related]
10. Anti-HLA, anti-human "Ia-like" and MLC blocking activity of human placental IgG.
Jeannet M; Werner C; Ramirez E; Vassalli P; Faulk WP
Transplant Proc; 1977 Jun; 9(2):1417-22. PubMed ID: 141758
[No Abstract] [Full Text] [Related]
11. [Lymphocyte suspensions greater than 2000/l per microliter sensitize HLA typing].
Májský A
Vnitr Lek; 1987 May; 33(5):468-71. PubMed ID: 3604068
[No Abstract] [Full Text] [Related]
12. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
[TBL] [Abstract][Full Text] [Related]
13. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
14. [Studies of anti-lymphocyte antibodies, with special reference to anti-B cell antibodies in choriocarcinoma].
Kajino T; Yuzawa H; Maruhashi T; Suzuki T; Kanazawa K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2267-73. PubMed ID: 6607298
[TBL] [Abstract][Full Text] [Related]
15. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
Hardy M; Suciu-Foca N; McKiernan T; Rohowsky C; Cianci J; Jacob J; Pierce J; Reemtsma K
Transplant Proc; 1979 Mar; 11(1):389-92. PubMed ID: 377661
[No Abstract] [Full Text] [Related]
16. [Xenoantisera against human B lymphocytes:possible detection of HLA-DR allospecificities (author's transl)].
Belvedere M; Richiardi P; Borelli I; Indiveri F
Haematologica; 1980 Feb; 65(1):34-44. PubMed ID: 6154632
[No Abstract] [Full Text] [Related]
17. [Attempt to use monocytes for HLA-DR typing].
Májský A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):293-300. PubMed ID: 6194062
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
19. Endothelial-monocyte antigens.
Stastny P
Transplant Proc; 1980 Sep; 12(3 Suppl 1):32-6. PubMed ID: 7001701
[TBL] [Abstract][Full Text] [Related]
20. [Proof of lymphocyte B antigens in microlymphocytotoxic tests (author's transl)].
Májský A
Cas Lek Cesk; 1976 Sep; 115(38):1183-6. PubMed ID: 1086139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
